mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0003 |
mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0004 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0004 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0004 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0004 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0004 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0005 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0005 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0005 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0006 |